CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Net sales	$ 258,655	$ 234,138	$ 755,622	$ 716,138
Cost of products sold	169,498	152,041	499,083	470,268
Gross profit	89,157	82,097	256,539	245,870
Selling expenses	28,777	27,348	86,430	82,044
General and administrative expenses	32,148	24,233	99,277	74,043
Research and development expenses	4,442	5,325	14,044	17,593
Amortization of intangibles	7,622	7,501	22,940	22,548
Operating expenses	72,989	64,407	222,691	196,228
Income from operations	16,168	17,690	33,848	49,642
Interest and debt expense	8,312	7,698	25,757	24,285
Investment (income) loss	(395)	(54)	(1,965)	(873)
Foreign currency exchange (gain) loss	492	3,128	904	2,730
Other (income) expense, net	(20)	1,029	(138)	25,512
Income (loss) before income tax expense (benefit)	7,779	5,889	9,290	(2,012)
Income tax expense (benefit)	1,781	1,929	595	442
Net income (loss)	$ 5,998	$ 3,960	$ 8,695	$ (2,454)
Average basic shares outstanding (in shares)	28,729	28,631	28,704	28,778
Average diluted shares outstanding (in shares)	28,941	28,888	28,906	28,778
Basic income (loss) per share (in dollars per share)	$ 0.21	$ 0.14	$ 0.30	$ (0.09)
Diluted income (loss) per share (in dollars per share)	0.21	0.14	0.30	(0.09)
Dividends declared per common share (in dollars per share)	$ 0.07	$ 0.07	$ 0.14	$ 0.14